Indirect readout in drug-DNA recognition: Role of sequence-dependent DNA conformation

Nucleic Acids Research

Volumn 36, Issue 2, 2008, Pages 376-386

  Araúzo Bravo, Marcos J ^a   Sarai, Akinori ^a  

^a KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; BENZIMIDAZOLE DERIVATIVE; CHROMOMYCIN A3; CONGOCIDINE; DAUNORUBICIN; DIAMIDINE DERIVATIVE; DISTAMYCIN A; DOXORUBICIN; ECHINOMYCIN; HALOGEN; IDARUBICIN; IMIDAZOLE; PENTAMIDINE DERIVATIVE; PROPAMIDINE; PYRROLE DERIVATIVE; QUINOXALINE; RADIOSENSITIZING AGENT; THIOPHENE DERIVATIVE;

ARTICLE; BASE PAIRING; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA CONFORMATION; DNA DETERMINATION; DNA DRUG COMPLEX; DNA SEQUENCE; DNA STRUCTURE; DRUG BINDING SITE; DRUG DNA BINDING; DRUG RESEARCH; MATHEMATICAL COMPUTING; NUCLEIC ACID DATABASE; PRIORITY JOURNAL; SCORING SYSTEM; STRUCTURE ANALYSIS;

EID: 39149101474     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm892     Document Type: Article

References (48)

1. Bischoff,G. and Hoffmann,S. (2002) DNA-binding of drugs used in medical therapies. Curr. Med. Chem., 9, 321-348.
2. Darnell,J.E. (2002) Transcription factors as targets for cancer therapy. Nat. Rev. Cancer, 2, 740-749.
3. Hurley,L.H. (2002) DNA and its associated processes as targets for cancer therapy. Nat. Rev. Cancer, 2, 188-200.
4. Rishton,G.M. (1997) Reactive compounds and in vitro false positives in HTS. Drug Discov. Today, 2, 382-384.
5. Sirois,S., Hatzakis,G., Wei,D., Du,Q. and Chou,K.C. (2005) Assessment of chemical libraries for their druggability. Comput. Biol. Chem., 29, 55-67.
6. Lin,J., Sahakian,D.C., de. Morais,S.M., Xu,J.J., Polzer,R.J. and Winter,S.M. (2003) The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery. Curr. Top. Med. Chem., 3, 1125-1154.
7. Lipinski,C.A., Lombardo,F., Dominy,B.W. and Feeney,P.J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 23, 3-25.
8. Chabner,B.A. and Roberts,TJr (2005) Chemotherapy and the war on cancer. Nat. Rev. Cancer, 5, 65-72.
9. Workman,P. (2005) Genomics and the second golden era of cancer drug development. Mol. Biosyst, 1, 17-26.
10. Evans,W.E. and Relling,M.V. (2064) Moving towards individualized mLdicine with pharmacogenomics. Nature, 429, 464-468.
11. Eichelbaum,M, Ingelman-Sundberg,M. and Evans,W.E. (2006) Pharmacogenomics and individualized drug therapy. Annu. Rev. Med., 57, 119-137.
12. Terfloth,L. (2003) Drug Design. In Gasteiger,J. and Engel,T. (eds), Chemoinformatics: A Textbook. 1st edn, Chapter 10.4. Wiley-VCH, London pp.593-618.
13. Coury,J.E., McFail-Isom,L., Williams,L.D. and Bottomley,L.A. (1996) A novel assay for drug-DNA. binding mode, affinity, and exclusion number: scanning force microscopy. Proc. Natl Acad. Sci. USA, 93, 12283-12286.
14. Ishchenko,A.A., Vasilenko,N.L., Sinitsina,O.I., Yamkovov,V.I., Fedorova,O.S., Douglas,K.T. and Nevinsky,G.A. (2002) Thermodynamic, kinetic, and structural basis for recognition and repair of 8-oxoguanine in DNA by Fpg protein from Escherichia coli. Biochemistry, 41 7540-7548.
15. Fischer,E. (1894) Einfluss der Configuration auf die Wirkung den Enzyme. Ber. Duch. Chem. Ges., 27, 2985-2993.
16. Koshland,D.E.Jr (1958) Application of a theory of enzyme specificity to protein synthesis. Proc. Natl Acad. Sci. USA, 44, 98-104.
17. Shaik,S.A., Ahmed,S.R. and Jayaram,B. (2004) A molecular thermodynamic view of DNA-drug interactions: A case study of 25 minor-groove binders. Arch. Biochem. Biophys., 429, 81-99.
18. Tobi,D. and Bahar,J. (2005) Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state. Proc. Natl Acad. Sci. USA, 102, 18908-18913.
19. Araúzo-Bravo,M.J., Fujii,S., Kono,H., Ahmad,S. and Sarai,A. (2005) Sequence-dependent conformational energy of DNA derived from molecular dynamics simulations: Toward understanding the indirect readout mechanism in protein-DNA recognition. J. Am. Chem. Soc., 127 16074-16089.
20. Sarai,A. and Kono,H. (2005) Protein-DNA recognition patterns and predictions. Ann. Rev. Biophys. Biomol. Struct., 34, 379-398.
21. Olson,W.K., Bansal,M., Burley,S.K., Dickerson,E., Gerstein,M., Harvey,E.C., Heinemann,U., Lu,X.J.; Neidle,S., Shakked,Z., Sklenar,H., Suzuki,M., Tung,C.S., Westhof,E., Wolberger,C. and Berman,H.M. (2001) A standard reference frame for the description of nucleic acid base pair geometry. J. Mol. Biol., 313, 229-237.
22. Dickerson,R.E., Bansal,M., Calladine.C.R, Diekmannn,S. Hunter,W.N., Kennard,O., Kitzing,E., Lavery,R., Nelson,H.C.M., Olson,W.K. and Saenger,W. (1989) Definitions and nomenclature of nucleic acid structure parameters. Nucleic Acids Res., 17, 1797-1803.
23. Lu,X.L. and Olson,W.K. (2003) A software package for the analysis, rebuilding and visualization of three-dimensional nucleic acid structures. Nucleic Acids Res., 31, 5108-5121.
24. Olson,W.K., Gorin,A.A., Lu,X.J., Mock,L.M. and Zhurkin,V.B. (1998) DNA sequenoe-dependent deformability deduced from protein-DNA crystal complexes. Proc. Natl Acad. Sci. USA, 95, 11163-11168.
25. Berman,H.M., Olson,W.K., Beveridge,D.L., Westbrook,J., Gelbin,A., Demeny,T., Hsieh,S.H., Srinivasan,A.R. and Schneider B. (1992) The nucleic acid database. A comprehensive relational database of throe-dimensional structures of nucleic acids. Biophys. J., 63 751-759.
26. Deshpande,N., Addess,K.J., Bluhm,W.F., Merino-Ott,J.C., Townsend-Merino,W., Zhang,Q., Knezevich,C., Lie,L., Chen,L., Feng,Z., Kramer-Green,R., Flippen-Anderson.J.L., Westbrook,J., Berman,H.M. and Bourne,P.E. (2005) The RCSB Protein Data Bank: A redesigned query system and relational database based on the mmCIF schema. Nucleic Acids Res. 33, D233-237.
27. Araúzo-Bravo,M.J. and Sarai,A. (2005) Knowledge-based prediction of DNA atomic structure from nucleic sequence. Genome Inform. Ser., 16, 12-21.
28. Lu,XT, Shakked,Z. and Olson,W.K. (2000) A-form conformational motifs in ligand-bound DNA structures. J. Mol. Biol., 300, 819-840.
29. Colson,P., Houssier,C. and Bailly,C. (1995) Use of electric linear dichroism and competition experiments with intercalating drugs to investigate the mode of binding of Hoechst 33258, berenil and DAPI to GC sequences. J. Biomol. Struct. Dyn., 13, 351-66.
30. Trotta,E., D'Ambrosio,E., Ravagnan,G. and Paci,M. (1995) Evidence for DAPI intercalation in CG sites of DNA oligomer [d(CGACGTCG)]2: A 1H NMR study. Nucleic Acids Res., 23, 1333-1340.
31. Jarque,C.M. and Bera,A.K. (1987) A test for normality of observations and regression residuals,. Int. Stal. Rev., 55, 1-10.
32. Waring,M.J. (1981) In Gale,E.F., Cundlifo,E., Richmond,M.H., Reynolds,P.E. and Waring,M.J. (eds), The Molecular Basis of Antibiotic Action. 2nd edn, Wiley, London, p. 287.
33. Drew,H.R., Wing,R.M., Takano,T., Broka,C., Tanaka,S., Itakura,K. and Dickerson,R.E. (1981) Structure of a B-DNA dodecamer: Conformation and dynamics. Proc. Natl Acad. Sci. USA, 78, 2179-2183.
34. O'Hare,C.C., Mack,D., Tandon,M., Sharma,S.K., Lown,J.W., Kopka,M.L., Dickerson,R.E. and Hartley,I.A. (2002) DNA sequence recognition in the minor groove by crosslinked polyamides: The effect of N-terminal head group and linker length on binding affinity and specificity. Proc. Natl Acad. Sci. USA, 99, 72-77.
35. Squire,CT, Baker,LT, Clark,G.R., Martin,R.F. and White,J. (2000) Structures of m-iodo Hoechst-DNA complexes in crystals with reduced solvent content: Implications for minor groove binder drug design. Nucleic Acid Res., 28, 1252-1258.
36. Cuesta-Seijo,J.A. and Sheldrick,G.M. (2005) Structures of complexes between echinomycin and duplex DNA. Acta Cryst., D61, 442-448.
37. Laurence,P.G.W. and Waring,MT (1976) The binding of echinomycin to deoxyribonucleic acid. Biochem. J., 157, 721-740.
38. Fox,K.R. and Kentebe,E (1990) Echinomycin binding to the sequence CG(AT)nCG alters the structure of the central AT region. Nucleic Acids Res., 18, 1957-1963.
39. 2 complex reveals GGCC binding specificity of the drug dimer chelated by a metal ion. Nucleic Acids Res., 32, 2214-2222.
40. Chatterjee,S., Zaman,K., Ryu,H., Conforto,A. and Ratan,R.R. (2001) Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis. induced by oxidative stress and DNA damage in cortical neurons. Ann. Neurol., 49, 345-354.
41. Hollingshead,L.M. and Faulds,D. (1991) Idarubicin: A review of its pharmacodynamic and pharcokinetic properties and therapeutic potential in the chemotherapy of cancer. Drugs, 42, 690-719.
42. Dautant,A., d'Estaintot,B.L., Gallois,B., Brown,T. and Hunter,W.N. (1995) A trigonal form of the idarubicin:d(CGATCG) complex; crystal and molecular structure at 2.0 A resolution. Nucleic Acids Res., 23 1710-1716.
43. Capranico,G., Buteffi,E. and Zunino,F. (1995) Change of the sequence specificity of daunorubicin-stimulated topoisomerase II. DNA cleavage by epimerizition of the amino group of the sugar moiety. Cancer Res., 55, 312-317.
44. Wang,A.H.-J., Gao,Y.-G., Liaw,Y.-C. and Li,Y.-K. (1991) Formaldehyde cross-links daunorubicin and DNA efficiently: HPLC and X-ray diffraction studies. Biochemistry, 30, 3812-3815.
45. Kalodimos,C.G., Biris,N., Bonvin,A.M.J.J., Levandoski,M., Guennuegues,M., Boelens,R. and Kaptein,R. (2004) Structure and flexibility adaptation in nonspecific and specific protein-DNA complexes. Science, 305, 386-389.
46. Gromiha,M.M., Siebers,J.G., Selvaraj,S., Kono,H. and Sarai,A. (2004) Intermolecular and intramolecular readout mechanisms in protein-DNA recognition. J. Mol. Biol., 337, 285-294.
47. Ge,W., Schneider,& and Olson,W.K. (2005) Knowledge-based elastic potentials for docking drugs or proteins with nucleic acids. Biophys. J., 88, 1166-1190.
48. Breslauer,K.J., Remeta,D.P., Chou,W.-Y., Ferrante,R., Curry,J., Zaunczkowski,D., Snyder,J.G. and Marky,L.A. (1987) Enthalpy-entropy compensations in drug-DNA binding studies thermodynamic driving forces/ drug-induced changes/probes of DNA conformation). Proc. Natl Acad Sci. USA, 84, 8922-8926.